| Lyndsey M Rogers, SLP-CFY | |
|
700 Franklin St, Socorro, NM 87801-4666 | |
| (575) 838-0800 | |
| Not Available |
| Full Name | Lyndsey M Rogers |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 700 Franklin St, Socorro, New Mexico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699908459 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | C4591 (New Mexico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lyndsey M Rogers, SLP-CFY 10647 Buck Island Rd Sw, Albuquerque, NM 87121-2647 Ph: (505) 440-6663 | Lyndsey M Rogers, SLP-CFY 700 Franklin St, Socorro, NM 87801-4666 Ph: (575) 838-0800 |
News Archive
With proof-of-principle in his pocket and a new $2.2 million grant from the National Institutes of Health, SLU scientist John Tavis, Ph.D., will take his 25 year mission to finally develop a cure for the hepatitis B virus into the next phase.
Chemists at the University at Buffalo have used rational drug design to synthesize small, cell-permeable molecules that are effective in vitro against two common types of myotonic muscular dystrophy, a result that has implications for potentially curing muscular dystrophy, as well as other diseases.
Michelle Snyder oversaw technology experts who helped build healthcare.gov and is the second administration official to leave after problems with the website where Americans can buy health insurance.
The development of nano-biosensors and nanoparticle-based vaccines and medicines has opened a new path toward better management of the coronavirus disease 2019 (COVID-19) pandemic. In a recently published article in the journal ACS Biomaterials Science & Engineering, scientists have reviewed recent advancements in nanotechnology-based diagnostic and therapeutic interventions against human coronaviruses.
Novartis announced today that the US Food and Drug Administration has granted three simultaneous approvals for the expanded use of Ilaris (canakinumab) to treat three rare and distinct types of Periodic Fever Syndromes.
› Verified 8 days ago
Ms. Tara K Jaramillo, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1115 N California St, Socorro, NM 87801 Phone: 505-838-0800 Fax: 505-838-3999 | |
Nice Speech Lady Llc Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 409 N California St, Socorro, NM 87801 Phone: 505-907-1902 Fax: 833-448-2997 | |
Lindsey Benjamin, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1115 N California St, Socorro, NM 87801 Phone: 575-838-0800 | |
Mrs. Wilson Nice, M.A., CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 409 N California St, Socorro, NM 87801 Phone: 505-907-1902 Fax: 833-448-2997 | |
Charlotte Ruth Wansa, M.A., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 700 Franklin St, Socorro, NM 87801 Phone: 575-835-0300 | |
Janet Vallese Brook, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1565 Bosquecito Road, Socorro, NM 87801 Phone: 505-835-2118 Fax: 505-835-2118 | |
Ms. Linda Snell Sanchez, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1115 N. California St, Socorro, NM 87801 Phone: 505-838-0800 Fax: 505-838-3999 |